Corrigendum to “Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice” [Chem. Biol. Interact. 206 (2013) 239–247] (Chemico-Biological Interactions (2013) 206(2) (239–247), (S000927971300241X), (10.1016/j.cbi.2013.09.016));Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice

Chemico-Biological Interactions

Volumn 206, Issue 2, 2013, Pages 239-247

  Kavitha, Mani ^a   Nataraj, Jagatheesan ^a   Essa, Musthafa Mohammed ^b   Memon, Mushtaq A ^c   Manivasagam, Thamilarasan ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Anti apoptosis; Behavior; Experimental Parkinson's disease; Mangiferin; Oxidative stress

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATALASE; DOPAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOVANILLIC ACID; MANGIFERIN; PROTEIN BAX; PROTEIN BCL 2; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DRUG DOSE COMPARISON; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; MOTOR DYSFUNCTION; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; TREATMENT DURATION;

MUS;

EID: 84885553390     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2020.109214     Document Type: Erratum

References (55)

1. R.D. Prediger, A.S. Aguiar Jr., E.L. Moreira, F.C. Matheus, A.A. Castro, R. Walz, A.F. De Bem, A. Latini, C.I. Tasca, M. Farina, and R. Raisman-Vozari The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease Curr. Pharm. Des. 17 2011 489 507
2. N. Lev, E. Melamed, and D. Offen Apoptosis and Parkinson's disease Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 245 250 (Pubitemid 36351491)
3. M. Gerlach, P. Riederer, and M.B. Youdim Molecular mechanisms for neurodegeneration: synergism between reactive oxygen species, calcium and excitotoxic amino acids Adv. Neurol. 69 1996 177 194
4. M. Alcaraz-Zubeldia, P. Rojas, C. Boll, and C. Ríos Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP Neurochem. Res. 26 2001 59 64 (Pubitemid 32428814)
5. N. Schmidt, and B. Ferger Neurochemical findings in the MPTP model of Parkinson's disease J. Neural Transm. 108 2001 1263 1282 (Pubitemid 33141302)
6. A. Gross, J.M. McDonnell, and S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis Genes Dev. 13 1999 1899 1911 (Pubitemid 29407357)
7. 2+-citrate Eur. J. Pharmacol. 513 2005 47 55 (Pubitemid 40692245)
8. A. Vyas, K. Syeda, A. Ahmad, S. Padhye, and F.H. Sarkar Perspectives on medicinal properties of mangiferin Mini Rev. Med. Chem. 12 2012 412 425
9. G. Garrido, D. Gonzalez, Y. Lemus, C. Delporte, and R. Delgado Protective effects of a standard extract of Mangifera indica L. (VIMANG) against mouse ear edemas and its inhibition of eicosanoid production in J774 murine macrophages Phytomedicine 13 2006 412 418 (Pubitemid 44250788)
10. L. Amazzal, A. Lapôtre, F. Quignon, and D. Bagrel Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells Neurosci. Lett. 418 2007 159 164 (Pubitemid 46636006)
11. Q. Zhao, J. Gao, W. Li, and D. Cai Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease Brain Res. 1346 2010 224 236
12. D. Muralikrishnan, and K.P. Mohanakumar Neuroprotection by bromocriptine against 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine induced neurotoxicity in mice FASEB J. 12 1998 905 912 (Pubitemid 28294680)
13. R.M. Deacon, E. Koros, K.D. Bornemann, and J.N. Rawlins Aged Tg2576 mice are impaired on social memory and open field habituation tests Behav. Brain Res. 197 2009 466 468
14. R. Haobam, K.M. Sindhu, G. Chandra, and K.P. Mohanakumar Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains Behav. Brain Res. 163 2005 159 167 (Pubitemid 41138049)
15. M. Mohanasundari, M.S. Srinivasan, S. Sethupathy, and M. Sabesan Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice J. Neurol. Sci. 249 2006 140 144 (Pubitemid 44665916)
16. S. Ferre, T. Guix, G. Prat, F. Jane, and M. Casas Is experimental catalepsy properly measured? Pharmacol. Biochem. Behav. 35 1990 753 757 (Pubitemid 20129970)
17. A. Bhattacharya, S. Ghosal, and S.K. Bhattacharya Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum J. Ethnopharmacol. 74 2001 1 6 (Pubitemid 32008512)
18. L.W. Oberley Inhibition of tumor cell growth by overexpression of manganese-containing superoxide dismutase Age (Omaha) 21 1998 95 97 (Pubitemid 29140796)
19. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
20. Y. Yamamoto, and K. Takahashi Glutathione peroxidase isolated from plasma reduces phospholipid hydroperoxide Arch. Biochem. Biophys. 305 1993 541 545 (Pubitemid 23282943)
21. D.J. Jollow, J.R. Mitchell, N. Zampaglione, and J.R. Gillette Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite Pharmacology 11 1974 151 169
22. M. Abercrombie Estimation of nuclear population from microtome sections Anat. Rec. 94 1946 239 247
23. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
24. N.A. Tatton, and S.J. Kish In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience 77 1997 1037 1048
25. J.M. Rabey, and R.S. Burns Neurochemistry W.J. Weiner, S.A. Factor, Parkinson's Disease: Diagnosis and Clinical Management 2002 Demos Medical Publishing New York, NY 195 211
26. M. Strolin Benedetti, and P. Dostert Monoamine oxidase, brain ageing and degenerative diseases Biochem. Pharmacol. 38 1989 555 561 (Pubitemid 19050093)
27. J. Saura, J.M. Luque, A.M. Cesura, M. Da Prada, V. Chan-Palay, G. Huber, J. Löffler, and J.G. Richards Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography Neuroscience 62 1994 15 30 (Pubitemid 24287342)
28. J. Knoll The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases J. Neural Transm. Suppl. 40 1993 69 91 (Pubitemid 24005558)
29. Y. Levites, O. Weinreb, G. Maor, M.B. Youdim, and S. Mandel Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration J. Neurochem. 78 2001 1073 1082 (Pubitemid 32823156)
30. S. Li, and X.P. Pu Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease Biol. Pharm. Bull. 34 2011 1291 1296
31. T. Himeda, N. Kadoguchi, Y. Kamiyama, H. Kato, H. Maegawa, and T. Araki Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity Neuropharmacology 50 2006 329 344 (Pubitemid 43184361)
32. T. Nagatsu Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity Neurochem. Res. 15 1990 425 429 (Pubitemid 20198303)
33. T. Nagatsu, T. Kato, Y. Numata, K. Ikuta, and M. Sano Phenylethanolamine N methyltransferase and other enzymes of catecholamine metabolism in human brain Clin. Chim. Acta 75 1977 221 232 (Pubitemid 8047079)
34. C.R. Borges, T. Geddes, J.T. Watson, and D.M. Kuhn Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress J. Biol. Chem. 277 2002 48295 48302 (Pubitemid 35470783)
35. D. Giustarini, R. Rossi, A. Milzani, R. Colombo, and I. Dalle-Donne S glutathionylation: from redox regulation of protein functions to human diseases J. Cell. Mol. Med. 8 2004 201 212 (Pubitemid 44145509)
36. A. Oyagi, Y. Oida, H. Hara, H. Izuta, M. Shimazawa, N. Matsunaga, T. Adachi, and H. Hara Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease Brain Res. 1214 2008 169 176
37. G.R. Uhl Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease Ann. Neurol. 43 1998 555 560 (Pubitemid 28225546)
38. E. Bezard, C.E. Gross, M.C. Fournier, S. Dovero, B. Bloch, and M. Jaber Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter Exp. Neurol. 155 1999 268 273 (Pubitemid 29124720)
39. B. Thomas, D. Muralikrishnan, and K.P. Mohanakumar In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine in mice Brain Res. 852 2000 221 224 (Pubitemid 30017755)
40. A. Bhattacharya, A. Chatterjee, S. Goshal, and S.K. Bhattacharya Antioxidant activity of tannoids priciples of Emblica officinalis (amla) Ind. J. Exp. Biol. 37 1999 676 680 (Pubitemid 29309692)
41. A. Anandhan, K. Tamilselvam, T. Radhiga, S. Rao, M.M. Essa, and T. Manivasagam Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease Brain Res. 1433 2012 104 113
42. D. Muralikrishnan, and K.P. Mohanakumar Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice FASEB J. 12 1998 905 912 (Pubitemid 28294680)
43. A. Munoz, P. Rey, M.J. Guerra, E. Mendez-Alvarez, R. Soto-Otero, and J.L. Labandeira-Garcia Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of Parkinsonism Neuropharmacology 51 2006 112 120
44. U. Wullner, P.A. Löschmann, J.B. Schulz, A. Schmid, R. Dringen, F. Eblen, L. Turski, and T. Klockgether Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurons Neuroreport 7 1996 921 923 (Pubitemid 26167978)
45. T. Hanakawa, Y. Katsumi, H. Fukuyama, M. Honda, T. Hayashi, J. Kimura, and H. Shibasaki Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study Brain 122 1999 1271 1282 (Pubitemid 29324848)
46. C.W. Olanow The pathogenesis of cell death in Parkinson's disease-2007 Mov. Disord. 22 2007 S335 S342
47. J.L. Tillerson, and G.W. Miller Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism J. Neurosci. Methods 123 2003 189 200 (Pubitemid 36279413)
48. S. Iyer, Understanding behavior and the brain through Parkinson's disease, Retrieved from Serendip website, 2000.
49. J.Y. Chen, P.C. Hsu, I.L. Hsu, and G.C. Yeh Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in C57BL/6 mice Neurosci. Lett. 314 2001 49 52 (Pubitemid 33043803)
50. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172 (Pubitemid 32524182)
51. J.C. Reed Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities Cell Death Differ. 13 2006 1378 1386 (Pubitemid 44057473)
52. T. Wang, L. Qin, B. Liu, Y. Liu, B. Wilson, T.E. Eling, R. Langenbach, S. Taniura, and J.S. Hong Role of reactive oxygen species in LPS induced production of prostaglandin E2 in microglia J. Neurochem. 88 2004 939 947 (Pubitemid 38199315)
53. R.A. Kirkland, J.A. Windelborn, J.M. Kasprzak, and J.L. Franklin A Bax-induced prooxidant/state is critical for cytochrome c release during programmed neuronal death J. Neurosci. 22 2002 6480 6490 (Pubitemid 35386404)
54. Q. Jiang, Z. Gu, G. Zhang, and G. Jing Diphosphorylation and involvement of extra-cellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons Brain Res. 857 2000 71 77 (Pubitemid 30107792)
55. M.R. Campos-Esparza, M.V. Sánchez-Gómez, and C. Matute Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols Cell Calcium 45 2009 358 368